AMA Lists Health Data Security, Telemedicine Among Top Issues Facing Physicians in 2016

Jan. 8, 2016
This week, the American Medical Association (AMA) released a list of the top nine issues physicians should follow closely in 2016, including a number of health IT issues, namely data security and telemedicine.

This week, the American Medical Association (AMA) released a list of the top nine issues physicians should follow closely in 2016 and a number of health IT issues, namely data security and telemedicine, made the list.

Medicare reform and the electronic health record (EHR) Meaningful Use program topped the list.  “The Merit-Based Incentive Payment System (MIPS) under development is intended to streamline the various reporting programs for physicians, and alternative payment models (APM) will support physicians in adopting new models of care. Shaping the MIPS so that it fixes the problems of the current system and is beneficial for both physicians and patients will be at the heart of Medicare reform efforts in the coming year,” the AMA wrote in a release.

The AMA said it would continue its work on this front, including a task force of physicians who already drafted and delivered to the Centers for Medicare & Medicaid Services (CMS) 10 principles to guide the foundation of the MIPS.

Regarding the MU EHR program, which the organization called a “burdensome regulatory program,” the AMA highlighted its work through a grassroots campaign called Break the Red Tape, which it began last year, calling for a reset of the meaningful use Stage 3 final rule.

Health data security and telemedicine were ranked No. 8 and 9, respectively. AMA stated that cyberattacks on health data are expected to increase this year.

“With such private information so vulnerable to attack, appropriate protections for sharing and data storage must be a focal point for health IT. The AMA is working with the federal government to ensure better protections for health information,” the AMA wrote.

And, AMA said telemedicine will see more widespread use in the upcoming year, citing its intention to advance the Interstate Medical Licensure Compact of the Federation of State Medical Boards, which facilitates state licensure for telemedicine.

“The AMA also will advocate for the removal of arbitrary barriers to telemedicine coverage under Medicare and promote AMA model state telemedicine legislation,” the organization said.

Other issues to make the Top 9 Issues list include insurance mergers, provider networks and balance billing, prescription drug abuse and addiction, graduate medical education funding and student debt relief and prescription drug costs.

Sponsored Recommendations

Ask the Expert: Is Your Patients' Understanding Putting You at Risk?

Effective health literacy in healthcare is essential for ensuring informed consent, reducing medical malpractice risks, and enhancing patient-provider communication. Unfortunately...

Beyond the Silos: Transforming Coordinated Care Across Healthcare Systems

Coordinated healthcare is vital to delivering a high-quality patient experience, yet it has been difficult to systematize across all healthcare settings. Although it has largely...

The Healthcare Provider's Guide to Accelerating Clinician Onboarding

Improve clinician satisfaction and productivity to enhance patient care

ASK THE EXPERT: ServiceNow’s Erin Smithouser on what C-suite healthcare executives need to know about artificial intelligence

Generative artificial intelligence, also known as GenAI, learns from vast amounts of existing data and large language models to help healthcare organizations improve hospital ...

According to an Oct. 10 press release, a report by the World Health Organization (WHO) finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR). While some of these vaccines are already available but underused, others would need to be developed and brought to the market as soon as possible. AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to antimicrobial medicines, making people sicker and increasing the risk of illness, death and the spread of infections that are difficult to treat. AMR is driven largely by the misuse and overuse of antimicrobials, yet, at the same time, many people around the world do not have access to essential antimicrobials. Each year, nearly 5 million deaths are associated with AMR globally. Vaccines are an essential part of the response to reduce AMR as they prevent infections, reduce the use and overuse of antimicrobials, and slow the emergence and spread of drug-resistant pathogens. The new report expands on a WHO study published in BMJ Global Health last year. It estimates that vaccines already in use against pneumococcus pneumonia, Haemophilus influenzae type B (Hib, a bacteria causing pneumonia and meningitis) and typhoid could avert up to 106 000 of the deaths associated with AMR each year. An additional 543 000 deaths associated with AMR could be averted annually when new vaccines for tuberculosis (TB) and Klebsiella pneumoniae, are developed and rolled out globally. While new TB vaccines are in clinical trials, one against Klebsiella pneumoniae is in early stage of development.
dreamstime_xxl_210174616_1